secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2026-06-23T20:05:20+00:00
Accession:  0001193125-26-279427
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA holds annual meeting, elects directors, appoints Hata Chairman and Rosen Lead Director
--------------------------------------------------------------------------------

- All three Class I director nominees elected: Hata (70.5M for), Hampton (56.7M for), Mackey (70.3M for).
- Ratification of PwC as independent auditor for 2026 passed with 82.6M votes in favor.
- Advisory say-on-pay proposal approved with 64.3M for, 8.3M against, 10.1M broker non-votes.
- Board elected Yujiro S. Hata as Chairman and Terry Rosen, Ph.D. as Lead Independent Director, effective June 16.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000119312526279427/0001193125-26-279427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000119312526279427/d39019d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-279427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer